DuPont de Nemours, Inc.
For the period ended Jun 30, 2025. Filed Aug 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Supplementary Information
NOTE 7 -SUPPLEMENTARY INFORMATION
| Sundry Income (Expense) - Net | Three Months Ended June 30, | Six Months Ended June 30, | ||
|---|---|---|---|---|
| In millions | 2025 | 2024 | 2025 | 2024 |
| Non-operating pension and other post-employment benefit credits | $1 | $3 | $4 | $10 |
| Interest income 1 | 20 | 21 | 41 | 41 |
| Foreign exchange (losses) gains, net | (18) | (4) | (21) | — |
| Loss on debt extinguishment 2 | — | (74) | — | (74) |
| Interest rate swap (loss) gain 3 | (27) | (39) | 51 | (39) |
| Miscellaneous income (expense) - net 4 | 11 | 6 | 13 | 13 |
| Sundry income (expense) - net | $(13) | $(87) | $88 | $(49) |
The three and six months ended June 30, 2025 and 2024 include interest on cash. Fluctuations in interest income are due to changes in cash balances and/or changes in interest rates.
The three and six months ended June 30, 2024 reflects the loss on the partial redemption of an aggregate principal amount of the 2038 Notes. Refer to Note 13 for further details.
The three months ended June 30, 2025 includes the non-cash mark-to-market loss related to the 2022 Swaps and 2024 Swaps and the interest settlement loss on the 2022 Swaps. The six months ended June 30, 2025 includes the non-cash mark-to-market net gain related to the 2022 Swaps and 2024 Swaps offset by the interest settlement loss on the 2022 Swaps. The three and six months ended June 30, 2024 include the mark to market loss related to the 2022 Swaps and 2024 Swap. Refer to Note 19 for further details.
Includes a benefit related to an adjustment of the Donatelle contingent earn-out liability. Refer to Note 3 for further details.
Cash, Cash Equivalents and Restricted Cash
At June 30, 2025 and December 31, 2024, the Company had $5 million and $6 million, respectively, within “Restricted cash and cash equivalents” in the interim Condensed Consolidated Balance Sheets. At June 30, 2025 and December 31, 2024, the Company also had $37 million and $36 million, respectively, within "Restricted cash and cash equivalents - noncurrent". The majority of the balance during both periods is attributable to the MOU cost sharing arrangement. Additional information can be found in Note 14.
Accrued and Other Current Liabilities
"Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets were $1,147 million at June 30, 2025 and $1,031 million at December 31, 2024. Accrued payroll, which is a component of "Accrued and other current liabilities," was $281 million at June 30, 2025 and $383 million at December 31, 2024. No other component of "Accrued and other current liabilities" was more than 5 percent of total current liabilities at June 30, 2025 and at December 31, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.